Long-term Benefit in Chronic Hepatitis B Patients After Standard Peginterferon Alfa Therapy
Clinical trial NCT03181113 · COMPLETED
Trial details
- NCT number
- NCT03181113
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-05-18
- Primary completion
- 2020-09-21
- Enrollment
- 473
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.